BN Business News
会社を追加 →
この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。

ビジネス · 1997/3/41 分で読めます

Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use; Amendment of Monograph for OTC Bronchodilator Drug Products; Correction

ローカル自動翻訳 · 情報源の原言語

概要

The Food and Drug Administration (FDA) is correcting a final monograph for over-the-counter (OTC) bronchodilator drug products that appeared in the Federal Register of May 20, 1996 (61 FR 25142). The document amended the final monograph for OTC bronchodilator drug products by removing pressurized metered-dose aerosol container dosage forms for the ingredients epinephrine, epinephrine bitartrate, and racepinephrine hydrochloride. The document was published with an inadvertent error in one of the amendatory instructions. This document corrects that error.

情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →

関連インサイト

ビジネスインサイト →